{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:14:32Z","timestamp":1790306072057,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"am","delay-in-days":262,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD023684-01A1"],"award-info":[{"award-number":["1S10OD023684-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK 007052"],"award-info":[{"award-number":["DK 007052"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F32 HL 152498-01"],"award-info":[{"award-number":["F32 HL 152498-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL 128304"],"award-info":[{"award-number":["R01 HL 128304"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL 133864"],"award-info":[{"award-number":["R01 HL 133864"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["16GRNT27250146"],"award-info":[{"award-number":["16GRNT27250146"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.yjmcc.2021.09.005","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T10:48:02Z","timestamp":1631702882000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress"],"prefix":"10.1016","volume":"162","author":[{"given":"Brittany G.","family":"Durgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Baust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yjmcc.2021.09.005_bb0005","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2021.09.005_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fmed.2019.00093","article-title":"Thin air, thick vessels: historical and current perspectives on hypoxic pulmonary hypertension","volume":"6","author":"Young","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"issue":"9","key":"10.1016\/j.yjmcc.2021.09.005_bb0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5551\/jat.RV17009","article-title":"The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases","volume":"24","author":"Abe","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.yjmcc.2021.09.005_bb0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","article-title":"NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle","volume":"136","author":"Stasch","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.09.005_bb0025","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2021.09.005_bb0030","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1038\/ncomms9482","article-title":"Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice","volume":"6","author":"Thoonen","year":"2015","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.yjmcc.2021.09.005_bb0035","doi-asserted-by":"crossref","first-page":"10763","DOI":"10.1073\/pnas.190333697","article-title":"Human recombinant soluble guanylyl cyclase: expression, purification, and regulation","volume":"97","author":"Lee","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"36","key":"10.1016\/j.yjmcc.2021.09.005_bb0040","doi-asserted-by":"crossref","first-page":"15959","DOI":"10.1021\/bi971825x","article-title":"Localization of the heme binding region in soluble guanylate cyclase","volume":"36","author":"Zhao","year":"1997","journal-title":"Biochemistry"},{"issue":"49","key":"10.1016\/j.yjmcc.2021.09.005_bb0045","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1021\/bi051601b","article-title":"Characterization of functional heme domains from soluble guanylate cyclase","volume":"44","author":"Karow","year":"2005","journal-title":"Biochemistry"},{"issue":"17","key":"10.1016\/j.yjmcc.2021.09.005_bb0050","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1073\/pnas.1301934110","article-title":"Higher-order interactions bridge the nitric oxide receptor and catalytic domains of soluble guanylate cyclase","volume":"110","author":"Underbakke","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.09.005_bb0055","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1074\/jbc.M706218200","article-title":"PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure","volume":"283","author":"Ma","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.09.005_bb0060","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.107.036368","article-title":"Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo","volume":"72","author":"Rothkegel","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.09.005_bb0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjp.0706792","article-title":"NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5\/6 nephrectomy","volume":"148","author":"Kalk","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.09.005_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.10","article-title":"Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"97","author":"Dasgupta","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"20","key":"10.1016\/j.yjmcc.2021.09.005_bb0075","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2021.09.005_bb0080","first-page":"1","article-title":"Soluble guanylate cyclase stimulators and activators","author":"Sandner","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.09.005_bb0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.09.005_bb0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.yjmcc.2021.09.005_bb0095","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.09.005_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCRESAHA.117.310705","article-title":"Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling","volume":"121","author":"Rahaman","year":"2017","journal-title":"Circ. Res."},{"issue":"19","key":"10.1016\/j.yjmcc.2021.09.005_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129183","article-title":"Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation","volume":"4","author":"Durgin","year":"2019","journal-title":"JCI Insight"},{"issue":"23","key":"10.1016\/j.yjmcc.2021.09.005_bb0110","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1182\/bloodadvances.2019000621","article-title":"Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice","volume":"3","author":"Wood","year":"2019","journal-title":"Blood. Adv."},{"issue":"12","key":"10.1016\/j.yjmcc.2021.09.005_bb0115","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1161\/ATVBAHA.114.303974","article-title":"Hemoglobin alpha\/eNOS coupling at myoendothelial junctions is required for nitric oxide scavenging during vasoconstriction","volume":"34","author":"Straub","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7424","key":"10.1016\/j.yjmcc.2021.09.005_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature11626","article-title":"Endothelial cell expression of haemoglobin alpha regulates nitric oxide signalling","volume":"491","author":"Straub","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yjmcc.2021.09.005_bb0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.09.005_bb0130","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCRESAHA.117.303776","article-title":"Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease","volume":"120","author":"Kraehling","year":"2017","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.09.005_bb0135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cbic.201100809","article-title":"Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat","volume":"13","author":"Surmeli","year":"2012","journal-title":"Chembiochem"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.09.005_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/j.2040-4603.2017.tb00750.x","article-title":"Regulation of coronary blood flow","volume":"7","author":"Goodwill","year":"2017","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.09.005_bb0145","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.yjmcc.2011.10.003","article-title":"Regulation of the human coronary microcirculation","volume":"52","author":"Beyer","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.09.005_bb0150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1378\/chest.07-1367","article-title":"The relationship between the components of pulmonary artery pressure remains constant under all conditions in both health and disease","volume":"133","author":"Syyed","year":"2008","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.09.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12742","article-title":"Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation","volume":"53","author":"Zhang","year":"2020","journal-title":"Cell Prolif."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.09.005_bb0160","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCRESAHA.112.300646","article-title":"Hypoxia-inducible factor-1alpha in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation","volume":"112","author":"Kim","year":"2013","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.09.005_bb0165","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41467-019-11500-6","article-title":"CD146-HIF-1alpha hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension","volume":"10","author":"Luo","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.09.005_bb0170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.CIR.0000050653.10758.6B","article-title":"Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity","volume":"107","author":"Zhao","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2021.09.005_bb0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1096\/fj.06-7526com","article-title":"Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP signaling","volume":"22","author":"Kirsch","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2021.09.005_bb0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/hc2901.093117","article-title":"Sildenafil inhibits hypoxia-induced pulmonary hypertension","volume":"104","author":"Zhao","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.09.005_bb0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCRESAHA.111.259242","article-title":"Pressure-overload-induced subcellular relocalization\/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation","volume":"110","author":"Tsai","year":"2012","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2021.09.005_bb0190","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/bph.14651","article-title":"Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells","volume":"176","author":"Zhang","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.09.005_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cellsig.2015.12.004","article-title":"Cyclic guanosine monophosphate compartmentation in human vascular smooth muscle cells","volume":"28","author":"Feiteiro","year":"2016","journal-title":"Cell. Signal."},{"issue":"51","key":"10.1016\/j.yjmcc.2021.09.005_bb0200","doi-asserted-by":"crossref","first-page":"43053","DOI":"10.1074\/jbc.M112.393892","article-title":"Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide","volume":"287","author":"Fernhoff","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.09.005_bb0205","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.105.581405","article-title":"Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling","volume":"113","author":"Dumitrascu","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.yjmcc.2021.09.005_bb0210","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/ATVBAHA.115.306133","article-title":"Cyclic GMP in vascular relaxation: export is of similar importance as degradation","volume":"35","author":"Krawutschke","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.09.005_bb0215","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/ATVBAHA.115.306217","article-title":"Relax: it\u2019s not all about degradation","volume":"35","author":"Stangherlin","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"24","key":"10.1016\/j.yjmcc.2021.09.005_bb0220","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1111\/bph.14835","article-title":"Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts","volume":"176","author":"Menges","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.09.005_bb0225","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","article-title":"Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study","volume":"128","author":"Bonderman","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.yjmcc.2021.09.005_bb0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11906-016-0645-6","article-title":"Soluble guanylate cyclase stimulators and activators: novel therapies for pulmonary vascular disease or a different method of increasing cGMP?","volume":"18","author":"Koress","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.09.005_bb0235","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study","volume":"146","author":"Bonderman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.yjmcc.2021.09.005_bb0240","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s004390050347","article-title":"A high-frequency polymorphism of NADH-cytochrome b5 reductase in African-Americans","volume":"99","author":"Jenkins","year":"1997","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.09.005_bb0245","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2141.2008.07017.x","article-title":"Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency","volume":"141","author":"Percy","year":"2008","journal-title":"Br. J. Haematol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:35:24Z","timestamp":1758314124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282821001772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":49,"alternative-id":["S0022282821001772"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.09.005","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}